Non-viral vectors for gene-based therapy

被引：2582

作者：

Yin, Hao ^{[1
]}

Kanasty, Rosemary L. ^{[1
,2
]}

Eltoukhy, Ahmed A. ^{[1
]}

Vegas, Arturo J. ^{[1
,3
]}

Dorkin, J. Robert ^{[1
,4
]}

Anderson, Daniel G. ^{[1
,2
,3
,5
,6
]}

机构：

[1] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA

[2] MIT, Dept Chem Engn, Cambridge, MA 02142 USA

[3] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA

[4] MIT, Dept Biol, Cambridge, MA 02142 USA

[5] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA

[6] MIT, Inst Med Engn & Sci, Cambridge, MA 02142 USA

来源：

NATURE REVIEWS GENETICS | 2014年 / 15卷 / 08期

基金：

美国国家卫生研究院; 美国国家科学基金会;

关键词：

IN-VIVO DELIVERY; PLASMID-LIPID PARTICLES; MODIFIED MESSENGER-RNA; TRANSGENE EXPRESSION; TARGETED DELIVERY; SLEEPING-BEAUTY; VIRAL VECTORS; ADMINISTERED SIRNA; NONHUMAN-PRIMATES; SYSTEMIC DELIVERY;

D O I：

10.1038/nrg3763

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Gene-based therapy is the intentional modulation of gene expression in specific cells to treat pathological conditions. This modulation is accomplished by introducing exogenous nucleic acids such as DNA, mRNA, small interfering RNA (siRNA), microRNA (miRNA) or antisense oligonucleotides. Given the large size and the negative charge of these macromolecules, their delivery is typically mediated by carriers or vectors. In this Review, we introduce the biological barriers to gene delivery in vivo and discuss recent advances in material sciences, nanotechnology and nucleic acid chemistry that have yielded promising non-viral delivery systems, some of which are currently undergoing testing in clinical trials. The diversity of these systems highlights the recent progress of gene-based therapy using non-viral approaches.

引用

页码：541 / 555

页数：15

共 159 条

[1] Phenotypic heterogeneity of the endothelium I. Structure, function, and mechanisms [J].

Aird, William C. .

CIRCULATION RESEARCH, 2007, 100 (02) :158-173

[2] Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].

Akinc, Akin ;

Querbes, William ;

De, Soma ;

Qin, June ;

Frank-Kamenetsky, Maria ;

Jayaprakash, K. Narayanannair ;

Jayaraman, Muthusamy ;

Rajeev, Kallanthottathil G. ;

Cantley, William L. ;

Dorkin, J. Robert ;

Butler, James S. ;

Qin, LiuLiang ;

Racie, Timothy ;

Sprague, Andrew ;

Fava, Eugenio ;

Zeigerer, Anja ;

Hope, Michael J. ;

Zerial, Marino ;

Sah, Dinah W. Y. ;

Fitzgerald, Kevin ;

Tracy, Mark A. ;

Manoharan, Muthiah ;

Koteliansky, Victor ;

de Fougerolles, Antonin ;

Maier, Martin A. .

MOLECULAR THERAPY, 2010, 18 (07) :1357-1364

[3] Development of Lipidoid-siRNA Formulations for Systemic Delivery to the Liver [J].

Akinc, Akin ;

Goldberg, Michael ;

Qin, June ;

Dorkin, J. Robert ;

Gamba-Vitalo, Christina ;

Maier, Martin ;

Jayaprakash, K. Narayanannair ;

Jayaraman, Muthusamy ;

Rajeev, Kallanthottathil G. ;

Manoharan, Muthiah ;

Koteliansky, Victor ;

Roehl, Ingo ;

Leshchiner, Elizaveta S. ;

Langer, Robert ;

Anderson, Daniel G. .

MOLECULAR THERAPY, 2009, 17 (05) :872-879

[4] Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery [J].

Alabi, Christopher A. ;

Love, Kevin T. ;

Sahay, Gaurav ;

Yin, Hao ;

Luly, Kathryn M. ;

Langer, Robert ;

Anderson, Daniel G. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (32) :12881-12886

[5] Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression [J].

Aleku, Manuela ;

Schulz, Petra ;

Keil, Oliver ;

Santel, Ansgar ;

Schaeper, Ute ;

Dieckhoff, Britta ;

Janke, Oliver ;

Endruschat, Jens ;

Durieux, Birgit ;

Roeder, Nadine ;

Loeffler, Kathrin ;

Lange, Christian ;

Fechtner, Melanie ;

Moepert, Kristin ;

Fisch, Gerald ;

Dames, Sibylle ;

Arnold, Wolfgang ;

Jochims, Karin ;

Giese, Klaus ;

Wiedenmann, Bertram ;

Scholz, Arne ;

Kaufmann, Joerg .

CANCER RESEARCH, 2008, 68 (23) :9788-9798

[6] Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].

Alexis, Frank ;

Pridgen, Eric ;

Molnar, Linda K. ;

Farokhzad, Omid C. .

MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515

[7] Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression [J].

Ambegia, E ;

Ansell, S ;

Cullis, P ;

Heyes, J ;

Palmer, L ;

MacLachlan, I .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1669 (02) :155-163

[8] Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L [J].

Anderson, Bart R. ;

Muramatsu, Hiromi ;

Jha, Babal K. ;

Silverman, Robert H. ;

Weissman, Drew ;

Kariko, Katalin .

NUCLEIC ACIDS RESEARCH, 2011, 39 (21) :9329-9338

[9] Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector [J].

Argyros, O. ;

Wong, S. P. ;

Niceta, M. ;

Waddington, S. N. ;

Howe, S. J. ;

Coutelle, C. ;

Miller, A. D. ;

Harbottle, R. P. .

GENE THERAPY, 2008, 15 (24) :1593-1605

[10] The Sleeping Beauty transposon system: a non-viral vector for gene therapy [J].

Aronovich, Elena L. ;

McIvor, R. Scott ;

Hackett, Perry B. .

HUMAN MOLECULAR GENETICS, 2011, 20 :R14-R20

← 1 2 3 4 5 6 7 8 9 10 →